0253-3766
2011 Issue 6
Analysis of diagnosis and treatment for 45 patients with gallbladder cancer
chen zong jing ; shi hong qi ; song qi tong ; chen gang ; jin yue peng ; zhang qi zuo
chen zong jing ; shi hong qi ; song qi tong ; chen gang ; jin yue peng ; zhang qi zuo
..............page:475-476
Robo1 expression in breast cancer and its relationship to brain metastasis
WANG Jing;WANG Le;LIU Fang-fang;MA Yong-jie;FU Li;LI Wen-liang;GU Feng
WANG Jing;WANG Le;LIU Fang-fang;MA Yong-jie;FU Li;LI Wen-liang;GU Feng
..............page:447-451
nm23-H1-siRNA enhances the chemosensitivity to liposome-encapsulated paclitaxel in lung adenocarcinoma cells in vitro
YANG Xue-qin;ZHANG Zhi-min;WANG Dong;WANG Ge;ZENG Ling-li;YANG Zhen-zhou
YANG Xue-qin;ZHANG Zhi-min;WANG Dong;WANG Ge;ZENG Ling-li;YANG Zhen-zhou
..............page:405-409
Relationship between BRCA1 mRNA expression in tumor cells from malignant effusions and chemosensitivity to cisplatin in patients with metastatic malignant effusions
QIAN Xiao-ping;LIU Bao-rui;JIANG Min;HU Jing;YU Li-xia;WANG Li-feng;HU Wen-jing;ZOU Zheng-yun
QIAN Xiao-ping;LIU Bao-rui;JIANG Min;HU Jing;YU Li-xia;WANG Li-feng;HU Wen-jing;ZOU Zheng-yun
..............page:457-460
Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma
ZOU Ji-dong;FU Hai-yan;XU Wei;L(U) Zheng-hua;CAO Hong-yuan;LUAN Xin-yong
ZOU Ji-dong;FU Hai-yan;XU Wei;L(U) Zheng-hua;CAO Hong-yuan;LUAN Xin-yong
..............page:461-464
Diagnostic value of CT-guided extrapleural locating transthoracic automated cutting needle biopsy of lung lesions
wei yue hua ; liao mei zuo ; xu li ying ; hu wei dong ; hu hui juan ; cao yi zuo
wei yue hua ; liao mei zuo ; xu li ying ; hu wei dong ; hu hui juan ; cao yi zuo
..............page:473-475
Inhibition of PDK1 gene expression in esophageal cancer EC9706 cells by RNA interference and its effect on their malignant biological behavior
YU Jing;CHEN Kui-sheng;LI Ya-nan;YANG Juan;ZHAO Lu
YU Jing;CHEN Kui-sheng;LI Ya-nan;YANG Juan;ZHAO Lu
..............page:410-414
ye wo xian pao zhuang ruan zu zhi rou liu yi li
xu shu juan ; xu lin na ; wu jia peng
xu shu juan ; xu lin na ; wu jia peng
..............page:469
State of art of the radiofrequency ablation of colorectal liver metastases
ZHAO Ming;WANG Jian-peng;WU Pei-hong
ZHAO Ming;WANG Jian-peng;WU Pei-hong
..............page:401-404
Clinical significance of C-reactive protein in patients with stage Ⅰ non-small cell lung cancer
SHEN Lan;LI Zi-ming;LU Shun
SHEN Lan;LI Zi-ming;LU Shun
..............page:442-446
Value of BI-RADS ultrasonic scores of direct and indirect ultrasonographic signs in diagnosis of solid breast lesions
GAO Jun-xi;YU Xiao-qin;YAO Lan-hui
GAO Jun-xi;YU Xiao-qin;YAO Lan-hui
..............page:465-469
Comparison of the effect of rh-endostatin on intratumoral and myocardial micrangium in mice
ZHANG Cui-cui;LI Kai;WEI Xi-yin;CHEN Cheng;YUAN Jing;WANG Jing
ZHANG Cui-cui;LI Kai;WEI Xi-yin;CHEN Cheng;YUAN Jing;WANG Jing
..............page:415-420
..............page:409,420,430,456,479-480
Abnormal expression of RSK-4 and its clinical significance in breast cancer
LIU Jian-lun;YANG Hua-wei;CHEN Zu-shun;JIANG Yi
LIU Jian-lun;YANG Hua-wei;CHEN Zu-shun;JIANG Yi
..............page:452-456
Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)
LIU Yi-qian;GUO Ren-hua;LIU Lian-ke;GAO Wen;ZHU Cheng-jun;WEI Juan;SHU Yong-qian
LIU Yi-qian;GUO Ren-hua;LIU Lian-ke;GAO Wen;ZHU Cheng-jun;WEI Juan;SHU Yong-qian
..............page:426-430
Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients
ZHENG Shu-tao;LIU Tao;Aerziguli·Tuersun;HUO Qi;LIU Qing;HUANG Cong-gai;FENG Jun-guo;L(U) Guo-dong;WANG Xing;LIN Ren-yong;Ilyar Sheyhidin;LU Xiao-mei
ZHENG Shu-tao;LIU Tao;Aerziguli·Tuersun;HUO Qi;LIU Qing;HUANG Cong-gai;FENG Jun-guo;L(U) Guo-dong;WANG Xing;LIN Ren-yong;Ilyar Sheyhidin;LU Xiao-mei
..............page:421-425
Advanced dermatofibrosarcoma protuberans treated with imatinib mesylate
ZHU Jian-hua;LI Qiu-wen;XIAO Wen-hua;SUN Jun-zhong;WANG Ru-liang;LU Jiang-yang
ZHU Jian-hua;LI Qiu-wen;XIAO Wen-hua;SUN Jun-zhong;WANG Ru-liang;LU Jiang-yang
..............page:470-473
gan zang e xing ji xian wei mu xi bao rou liu yi li
yan tao ; bi xin yu ; zhang hong tu ; zhao jian jun ; zhang lei ; huang zhen ; zhou hai tao ; li cong ; cai jian qiang
yan tao ; bi xin yu ; zhang hong tu ; zhao jian jun ; zhang lei ; huang zhen ; zhou hai tao ; li cong ; cai jian qiang
..............page:477-478
Association of serum EGFR protein concentration with the efficacy of Gefitinib in the treatment of advanced non-small cell lung cancer
LI Bei;WANG Yan;ZHU Hong-xia;LI Jun-ling;HU Xing-sheng;WANG Bin;HAO Xue-zhi;WANG Lin;ZHANG Xiang-ru;SHI Yuan-kai
LI Bei;WANG Yan;ZHU Hong-xia;LI Jun-ling;HU Xing-sheng;WANG Bin;HAO Xue-zhi;WANG Lin;ZHANG Xiang-ru;SHI Yuan-kai
..............page:431-435
Value of serum carcinoembryonic antigen in prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor
XU Chong-an;SU He;LIU Jia-li;LI Lin;ZOU Hua-wei
XU Chong-an;SU He;LIU Jia-li;LI Lin;ZOU Hua-wei
..............page:436-441